In order to locally deliver low-intensity electric fields in proximity of HER-positive breast cancer cells (e.g., SK-BR-3), BTNPs have been functionalized with anti-HER2 antibody through streptavidin-biotin conjugation33. This evidence concerns the gene ERBB2 and breast cancer.